Clinical Outcomes Associated With Ibuprofen Use During COVID-19
A team of investigators assessed clinical outcomes among patients with COVID-19 receiving ibuprofen for fever reduction.
Emerging Diseases
Clinical Benefit Observed With Colchicine in Hospitalized COVID-19 Patients
The open-label, prospective study (GRECCO-19) assessed the effect of treatment with low-dose colchicine on cardiac and inflammatory biomarkers as well as clinical outcomes.
Aviptadil Fast-Tracked for Respiratory Distress in COVID-19
The FDA has granted Fast Track designation to RLF-100 (Aviptadil; NeuroRx and Relief Therapeutics) for the treatment of acute lung injury/acute respiratory distress syndrome associated with coronavirus disease 2019.
Many Practice Unsafe Household Cleaning Against COVID-19
More than one-third of U.S. adults admit to unsafe cleaning practices in the hopes of disinfecting against COVID-19.
COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient
Gilead Sciences, the maker of remdesivir, the first drug that showed promise in treating COVID-19 infections, will charge U.S. hospitals $3,120 for a patient with private insurance.
Chronic Fatigue Syndrome, Viruses, and the Innate Immune System
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a disorder characterized by marked fatigue, exertion induced malaise, cognitive clouding (or brain fog), impaired academic/work performance, disrupted sleep, and joint/muscle pain.
Phase 1 Study of Adjuvanted COVID-19 Vaccine Candidate Begins
A phase 1 study evaluating the safety, reactogenicity and immunogenicity of SCB-2019, a vaccine candidate for coronavirus disease 2019 (COVID-19), has been initiated by Clover Biopharmaceuticals.
Distinguishing ILD From COVID-19 in Patients Treated With EGFR-TKIs
Optimal treatment of patients with EGFR-TKI–associated ILD is based on rapid diagnosis and the timely implementation of specific interventions.
Significant QT Prolongation Associated With Chloroquine/Hydroxychloroquine Treatment for COVID-19
The treatment of patients with COVID-19 with chloroquine or hydroxychloroquine may result in significant QT prolongation.
Healthcare Systems in New York City Implement Joint Telehealth Program for Children With Obesity During the COVID-19 Pandemic
Healthcare systems in New York City have partnered to support vulnerable children with obesity using a telehealth weight management program.
-
Loading...
-
Loading...
Next post in Pediatric Illnesses
